AD vs Control CircRNAs, Human Temporal Lobe, Synaptosome.
收藏数据链接：
官方服务：
资源简介：
AD vs Control CircRNAs, Human Temporal Lobe, Synaptosome.
应用场景：
创建时间：
2024-07-29
相关数据集
Table_2_The Key Factors Predicting Dementia in Individuals With Alzheimer’s Disease-Type Pathology.DOCX
Dementia affects millions of individuals worldwide, yet there are no effective treatments. Alzheimer’s disease, the most common form of dementia, is characterized by amyloid and tau pathology with amy
NIAID Data Ecosystem50
The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
A major difference in the revised diagnostic criteria for Alzheimer’s disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow the identification of preclinical AD due
NIAID Data Ecosystem30
Association of top hits with additional phenotypes of interest.
Results of association with respective plasma analytes, CSF analytes levels in samples with low AB42 (evidence of amyloid deposition), those with high AB42 (no evidence of deposition) is shown for eac
Figshare2015-12-02 更新20
Supplementary Material for: Automatic assessment of connected speech and its relation to memory in Alzheimer's Disease in low education
Introduction: Discourse is one of the main linguistic aspects affected by Alzheimer’s Disease (AD) and its relationship with memory needs to be further studied, mainly in low education and low socioec
NIAID Data Ecosystem30
Table 1_Integrative single-cell and cell-free plasma RNA transcriptomics identifies biomarkers for early non-invasive AD screening.xlsx
IntroductionData-driven omics approaches have rapidly advanced our understanding of the molecular heterogeneity of Alzheimer’s disease (AD). However, limited by the unavailability of brain tissue, the
NIAID Data Ecosystem20
